Pages that link to "Q36901936"
Jump to navigation
Jump to search
The following pages link to Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. (Q36901936):
Displaying 50 items.
- Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis (Q26746659) (← links)
- Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist (Q26748085) (← links)
- Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration (Q30885473) (← links)
- Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial (Q34092311) (← links)
- Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment (Q34563216) (← links)
- The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis (Q35135726) (← links)
- Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients. (Q35564852) (← links)
- Comprehensive appraisal of magnetic resonance imaging findings in sustained rheumatoid arthritis remission: a substudy (Q35788326) (← links)
- Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis (Q35891702) (← links)
- Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone (Q36064796) (← links)
- Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. (Q36193944) (← links)
- Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study (Q36573102) (← links)
- Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial (Q36640598) (← links)
- Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker (Q36907478) (← links)
- Primary care-based screening for cardiovascular risk factors in patients with psoriasis. (Q37420435) (← links)
- Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate? (Q37651150) (← links)
- Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease (Q37707747) (← links)
- Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm (Q38115132) (← links)
- Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions (Q38293477) (← links)
- Atherosclerosis in rheumatoid arthritis: is it all about inflammation? (Q38396964) (← links)
- Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism (Q38741861) (← links)
- Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis (Q38745362) (← links)
- Cardiovascular disease in patients with rheumatoid arthritis (Q38950371) (← links)
- Methotrexate enhances 3T3-L1 adipocytes hypertrophy. (Q39108736) (← links)
- Managing Cardiovascular Disease Risk in Rheumatoid Arthritis: Clinical Updates and Three Strategic Approaches (Q39210337) (← links)
- Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis (Q40959053) (← links)
- Effects of Pomegranate (Punica Granatum L.) Seed and Peel Methanolic Extracts on Oxidative Stress and Lipid Profile Changes Induced by Methotrexate in Rats (Q41126517) (← links)
- Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial (Q41914520) (← links)
- Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications (Q41921823) (← links)
- Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis (Q43524523) (← links)
- Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid Arthritis (Q44067316) (← links)
- The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis (Q44558171) (← links)
- Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDs. (Q46172380) (← links)
- Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors (Q47098257) (← links)
- Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study (Q48508157) (← links)
- Lipids in RA: Is Less Not Necessarily More? (Q49721726) (← links)
- Lipid profile and effect of statin treatment in pooled phase II and phase III baricitinib studies (Q49792187) (← links)
- Risk factors for cardiovascular disease in rheumatoid arthritis patients from Mato Grosso do Sul. (Q50985464) (← links)
- The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report. (Q51243846) (← links)
- Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. (Q52312175) (← links)
- Atherosclerotic vascular disease in the autoimmune rheumatologic woman. (Q52372999) (← links)
- Association between inflammation and systolic blood pressure in RA compared to patients without RA. (Q55043697) (← links)
- An unfavorable body composition is common in early arthritis patients: A case control study. (Q55431083) (← links)
- Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis (Q57067660) (← links)
- Clinical and Genetic Risk Factors Associated with Psoriatic Arthritis among Patients with Psoriasis (Q57807815) (← links)
- Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis (Q58609925) (← links)
- Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate (Q59135667) (← links)
- The effects of conventional drugs in the treatment of rheumatoid arthritis on the serum lipids (Q61454160) (← links)
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (Q63694272) (← links)
- Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: Associations in rheumatoid arthritis patients (Q87621947) (← links)